Long-term clinical control of feline pancreatic carcinoma with toceranib phosphate

Authors

Andrea M. Dedeaux, Department of Veterinary Clinical Sciences (Dedeaux, Boudreaux) and the Department of Pathobiological Sciences (Langohr), School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive, Baton Rouge, Louisiana 70803, USA.
Ingeborg M. Langohr, Department of Veterinary Clinical Sciences (Dedeaux, Boudreaux) and the Department of Pathobiological Sciences (Langohr), School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive, Baton Rouge, Louisiana 70803, USA.
Bonnie B. Boudreaux, Department of Veterinary Clinical Sciences (Dedeaux, Boudreaux) and the Department of Pathobiological Sciences (Langohr), School of Veterinary Medicine, Louisiana State University, Skip Bertman Drive, Baton Rouge, Louisiana 70803, USA.

Document Type

Article

Publication Date

7-1-2018

Abstract

An 11-year-old, spayed female, domestic shorthair cat was presented with a non-resectable abdominal mass diagnosed as carcinomatosis of pancreatic origin. Treatment with toceranib phosphate was started. Abdominal ultrasound approximately 1 year after diagnosis revealed progressive disease. The cat was humanely euthanized approximately 792 days after initial presentation due to progressive clinical signs.

Publication Source (Journal or Book title)

The Canadian veterinary journal = La revue veterinaire canadienne

First Page

751

Last Page

754

Recommended Citation

Dedeaux, A. M., Langohr, I. M., & Boudreaux, B. B. (2018). Long-term clinical control of feline pancreatic carcinoma with toceranib phosphate. The Canadian veterinary journal = La revue veterinaire canadienne, 59 (7), 751-754. Retrieved from https://repository.lsu.edu/vetmed_pubs/902